Allergic Asthma
📧 Sign up to get email alerts when something new happens for Allergic Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma [Phase 3]
Phase 3 trial update reporting efficacy and safety of Zerafil (Omalizumab) in uncontrolled moderate-to-severe allergic asthma.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma [Phase 2]
Phase 2 trial investigating tezepelumab with methacholine-induced airway hyperresponsiveness in adults with mild allergic asthma; status and…
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Anti-inflammatory Effects Glycopyrronium [Phase 3]
Phase 3 clinical trial update on glycopyrronium with anti-inflammatory effects in asthma and allergic asthma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety for treatment of house dust mite–induced allergic asthma and perennial allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients [Phase 2]
Phase 2 trial assessing the effects of tregalizumab on allergen-induced airway responses and airway inflammation in patients with allergic a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. [Phase 3]
Phase 3 trial update on an anti-IgE monoclonal antibody for allergic asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses [Phase 4]
Phase 4 trial update evaluating tiotropium for efficacy against allergen-induced early asthmatic responses in allergic asthma.
-
FDA label_change · 2021-04-09FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for XOLAIR (omalizumab) filed by Genentech to modify the labeling.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure [Phase 2]
Phase 2 trial assessing whether gamma tocopherol-enriched supplementation alters response to inhaled ozone exposure in individuals with alle…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest [NA]
This clinical trial update evaluates whether a tape-based skin prick test provides diagnostically equivalent results to the conventional Ski…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract [Phase 2]
Phase 2 study evaluating the biological standardization of Dermatophagoides pteronyssinus allergen extract has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy [Phase 4]
Phase 4 trial update describing inflammatory cell types in moderate to severe pediatric asthma while on anti-IgE therapy, focusing on eosino…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics [NA]
A completed clinical trial evaluated the role of vitamin E in modulating asthmatic responses in individuals with allergic asthma. Results we…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils [Phase 4]
Phase 4 trial assessed whether basophil biomarker responses (anti-IgE antibodies or Syk expression) can predict how patients with allergic a…
-
CLINICAL_TRIALS other · 2017-07-06Clinical Trial Update: House Dust Mite Injection Immunotherapy in Elderly Patients. [Phase 3]
A Phase 3 trial evaluating house dust mite injection immunotherapy in elderly patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Cobra (Severe Asthma)Medical-economic
The Cobra trial evaluating a treatment for allergic asthma with severe features has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children [Phase 3]
This update presents long-term safety, tolerability, and efficacy data for omalizumab in Japanese children with allergic asthma from a Phase…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma [Phase 2]
Phase 2 study evaluating the effect of roflumilast on airway inflammation and function after allergen challenge in subjects with allergic as…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: The Effect of Salmeterol on Eosinophil (EOS) Function [NA]
This clinical trial update assesses how salmeterol affects eosinophil function in allergic asthma. The study is complete, with results poste…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the efficacy of QGE031 compared with omalizumab in patients with allergic asthma.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen [Phase 2]
Phase 2 trial evaluating tolerability and effects of AZD8848 in subjects with allergic asthma; the study has completed and results have been…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma [Phase 2, Phase 3]
A clinical trial update evaluating the safety and efficacy of omalizumab for allergic asthma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
A completed clinical trial assessed the effect of allergen immunotherapy on exhaled nitric oxide in adults with allergic asthma and allergic…
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
A completed pharmacosurveillance trial evaluating Xolair (omalizumab) dosing in patients with and without a history of anaphylactic reaction…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Efficacy Of Bacterial Lysate In Asthmatic Children [Phase 3]
Phase 3 trial evaluating the efficacy of a bacterial lysate in children with allergic asthma has completed.